Mustafa Ozgul, MD

Mustafa Ozgul, MD is the CEO and Founder of A1 Diagnosis, developing the world’s first AI-powered blood test that detects biomarker alterations associated with AMD risk years before symptoms appear. His work combines six years of native peptide biomarker research at UC Irvine’s Gavin Herbert Eye Institute, 24 peer-reviewed publications, and machine learning classification to bridge clinical medicine and AI.